Subba Chintalacharuvu is an Executive Director of Translational Immunology at Genentech, where they lead efforts in developing life-changing medicines for patients. With extensive experience in preclinical and translational development across various therapeutic areas, Subba has successfully contributed to 16 IND documents, leading to the approval of one drug and multiple compounds in clinical trials. They have held roles in renowned companies such as Eli Lilly and Company, GSK, and Corbus Pharmaceuticals, focusing on drug discovery and managing diverse portfolios. Subba holds a Ph.D. in Immunology from Case Western Reserve University and an MBA from Indiana University - Kelley School of Business.
Location
South San Francisco, United States
This person is not in any teams
This person is not in any offices